PGHZ.L
PCGH ZDP Plc [PGHZ.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PGHZ.L Stock Summary
Top 10 Correlated ETFs
PGHZ.L
Top 10 Correlated Stocks
PGHZ.L
In the News
PGHZ.L Financial details
Company Rating
Neutral
Market Cap
38.88M
Income
0
Revenue
2.22M
Book val./share
1
Cash/share
1
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
20 May 2021
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
121
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
2.39%
Revenue Q/Q
2.09%
EPS Q/Q
-
-
-
-
-
SMA20
0.83%
SMA50
1.68%
SMA100
3.42%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
114.05-122.96
52W High
-0.82%
52W Low
+6.14%
RSI
-
Rel Volume
0.02
Avg Volume
8.52K
Volume
180
Perf Week
0%
Perf Month
1.68%
Perf Quarter
3.86%
Perf Half Y
3.86%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0.59%
Prev Close
0%
Price
121
Change
0%
PGHZ.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-09-30
| Metric | History | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 20.01 | 20.64 | 21.24 | 21.88 | 22.52 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 20.01 | 20.64 | 21.24 | -21.88 | -22.52 | |
| Free cash flow per share | 20.01 | 20.64 | 21.24 | -21.88 | -22.52 | |
| Cash per share | 1 | 1 | 1 | 1 | 1 | |
| Book value per share | 1 | 1 | 1 | 1 | 1 | |
| Tangible book value per share | 1 | 1 | 1 | 1 | 1 | |
| Share holders equity per share | 1 | 1 | 1 | 1 | 1 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 54.25K | 53.75K | 56.75K | 57K | 58K | |
| Enterprise value | 4.25K | 3.75K | 6.75K | 7K | 8K | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |
| POCF ratio | 0.05 | 0.05 | 0.05 | -0.05 | -0.05 | |
| PFCF ratio | 0.05 | 0.05 | 0.05 | -0.05 | -0.05 | |
| P/B Ratio | 1.09 | 1.08 | 1.14 | 1.14 | 1.16 | |
| PTB ratio | 1.09 | 1.08 | 1.14 | 1.14 | 1.16 | |
| EV to sales | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Enterprise value over EBITDA | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| EV to operating cash flow | 0 | 0 | 0.01 | -0.01 | -0.01 | |
| EV to free cash flow | 0 | 0 | 0.01 | -0.01 | -0.01 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 18.44 | 19.2 | 18.72 | -19.19 | -19.41 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.05 | -0.05 | -0.05 | -0.05 | -0.04 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -686.46 | -707.1 | -728.34 | -750.22 | -772.74 | |
| Working capital | 50K | 50K | 50K | 50K | 50K | |
| Tangible asset value | 50K | 50K | 50K | 50K | 50K | |
| Net current asset value | -34.32M | -35.35M | -36.42M | -37.51M | -38.64M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q4
| Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 10.74 | 10.82 | 11.06 | 11.14 | 11.38 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 10.74 | 10.82 | -10.82 | -11.14 | -11.38 | |
| Free cash flow per share | 10.74 | 10.82 | -10.82 | -11.14 | -11.38 | |
| Cash per share | 1 | 1 | 1 | 1 | 1 | |
| Book value per share | 1 | 1 | 1 | 1 | 1 | |
| Tangible book value per share | 1 | 1 | 1 | 1 | 1 | |
| Share holders equity per share | 1 | 1 | 1 | 1 | 1 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 56.75K | 57.25K | 57K | 57K | 58K | |
| Enterprise value | 6.75K | 7.25K | 7K | 7K | 8K | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0.11 | 0.11 | 0.1 | 0.1 | 0.1 | |
| POCF ratio | 0.11 | 0.11 | -0.11 | -0.1 | -0.1 | |
| PFCF ratio | 0.11 | 0.11 | -0.11 | -0.1 | -0.1 | |
| P/B Ratio | 1.14 | 1.15 | 1.14 | 1.14 | 1.16 | |
| PTB ratio | 1.14 | 1.15 | 1.14 | 1.14 | 1.16 | |
| EV to sales | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Enterprise value over EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| EV to operating cash flow | 0.01 | 0.01 | -0.01 | -0.01 | -0.01 | |
| EV to free cash flow | 0.01 | 0.01 | -0.01 | -0.01 | -0.01 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 9.46 | 9.45 | -9.49 | -9.77 | -9.81 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.09 | -0.09 | -0.09 | -0.09 | -0.09 | |
| Current ratio | 0 | 0 | 0 | 0 | 0 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | -728.34 | -739.16 | -750.22 | -761.36 | -772.74 | |
| Working capital | 50K | 50K | 50K | 50K | 50K | |
| Tangible asset value | 50K | 50K | 50K | 50K | 50K | |
| Net current asset value | -36.42M | -36.96M | -37.51M | -38.07M | -38.64M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
PGHZ.L Frequently Asked Questions
What is PCGH ZDP Plc stock symbol ?
PCGH ZDP Plc is a GB stock and trading under the symbol PGHZ.L
What is PCGH ZDP Plc stock quote today ?
PCGH ZDP Plc stock price is $121 today.
Is PCGH ZDP Plc stock public?
Yes, PCGH ZDP Plc is a publicly traded company.
Company Profile
- Volume Average 8.52K
- Market Capitalization 38.88M
- Headquarters London,GB
- IPO Date 2017-06-20
-
Website
https://www.polarcapitalhealthcaretrust.com 
PCGH ZDP Plc is a debt issuing vehicle for Polar Capital Global Healthcare Trust plc. The company was incorporated in 2017 and is headquartered in London, United Kingdom.
